FdaApplication
NDA 021729
Identifiers
- fda_app_no: NDA021729
Properties
| Property | Value |
|---|---|
| applicant_name | OTSUKA PHARMACEUTICAL CO LTD |
| application_type | NDA |
| approval_date | 2006-06-07 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ABILIFY | ARIPIPRAZOLE | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING;ORAL |
| ABILIFY | ARIPIPRAZOLE | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING;ORAL |
| ABILIFY | ARIPIPRAZOLE | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING;ORAL |
| ABILIFY | ARIPIPRAZOLE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING;ORAL |
4 products